USCWA
COLL icon

U.S. Capital Wealth Advisors’s Collegium Pharmaceutical COLL Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,400
Closed -$55.7K – 812
2022
Q4 		$55.7K Buy
+2,400
New +$48.4K ﹤0.01% 856

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

U.S. Capital Wealth Advisors's COLL Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Collegium Pharmaceutical (COLL) in Q1 2023, closing a stake of 2,400 shares — an estimated $55.7K sold.

U.S. Capital Wealth Advisors first reported a position in COLL in Q4 2022 and held it in 1 quarter. The position peaked at $55.7K in Q4 2022. 198 funds tracked by Wall St. Rank hold COLL as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Collegium Pharmaceutical position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 2,400 Collegium Pharmaceutical shares in Q1 2023, an estimated $55.7K.
  • U.S. Capital Wealth Advisors first reported a position in Collegium Pharmaceutical in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Collegium Pharmaceutical position peaked at $55.7K in Q4 2022.
  • 198 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.